UnitedHealth Group delivered a profit beat for the quarter, but not the kind that investors wanted to see. Heard on the ...

UnitedHealth's stock was diving 3.7%, to pull back from a record high, and enough to pace the Dow's premarket losers, after ...

Medical costs continue to surge more than expected for health insurers.

UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

I discuss and analyze UNH's cautious FY2025 guidance, attributing lower bottom-line to various factors. Click here to read my ...

UnitedHealth Group stock fell more than 8% in early trading Tuesday as the Minnesota-based health care giant reported higher ...

Key Takeaways UnitedHealth Group shares declined Tuesday after the company lowered its full-year earnings per share (EPS) ...

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies on Tuesday morning, where ...

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. However, I rate it as a Buy. The company's long-term EPS growth target of 13-16% ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

UnitedHealth Group (NYSE: UNH) 在2024年第三季度财报电话会议上重申了全年盈利展望，尽管面临Medicare费率削减和Medicaid会员资格重新认定等挑战。公司报告了强劲增长，在商业产品中服务超过200万新消费者，并通过Optum Rx完成了16亿次处方配药。 UnitedHealth Group报告第三季度表现强劲，首席执行官Andrew Witty强调了公司的 ...

On Wednesday, KeyBanc made an adjustment to the stock price target for UnitedHealth Group (NYSE:UNH), reducing it from $675.00 to $650.00, while maintaining an Overweight rating on the stock.